oleic acid has been researched along with dactinomycin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chandrasekaran, C; Cooper, AD; Ellsworth, JL | 1 |
| Giller, T; Hennes, U; Imbach, AP; Kempen, HJ; Nakada, N; Neumann, WJ | 1 |
| Antras-Ferry, J; Forest, C; Le Bigot, G; Robin, D; Robin, P | 1 |
| Barber, T; Brasaemle, DL; Kimmel, AR; Londos, C | 1 |
| Ito, Y; Kasai, T; Kondo, N; Naganawa, T; Nakashima, S; Nozawa, Y; Ohguchi, K | 1 |
| Bastin, J; Djouadi, F; Ouali, F | 1 |
| Bogdanova, K; Poczatkova, H; Rypka, M; Uherkova, L; Vesely, J | 1 |
8 other study(ies) available for oleic acid and dactinomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.
Topics: Acetates; Animals; Blood; Blotting, Northern; Blotting, Western; Cholesterol; Dactinomycin; DNA; DNA Probes; Electrophoresis, Polyacrylamide Gel; Hydroxymethylglutaryl CoA Reductases; Kinetics; Lipoproteins, LDL; Liver Neoplasms, Experimental; Male; Mevalonic Acid; Oleic Acid; Oleic Acids; Rats; Rats, Inbred Strains; Receptors, LDL; RNA, Neoplasm; Sterols; Tumor Cells, Cultured | 1991 |
Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors.
Topics: Apolipoprotein A-I; Apolipoproteins B; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose; Glycolysis; Hexoses; Humans; Lipids; Liver; Oleic Acid; Oleic Acids; Protein Synthesis Inhibitors; RNA, Messenger; Tumor Cells, Cultured | 1995 |
Stimulation of phosphoenolpyruvate carboxykinase gene expression by fatty acids.
Topics: 3T3 Cells; Actins; Adipocytes; Animals; Culture Media, Serum-Free; Cycloheximide; Dactinomycin; Gene Expression; Kinetics; Liver Neoplasms, Experimental; Mice; Oleic Acid; Oleic Acids; Phosphoenolpyruvate Carboxykinase (GTP); RNA, Messenger; Time Factors | 1994 |
Post-translational regulation of perilipin expression. Stabilization by stored intracellular neutral lipids.
Topics: 3T3 Cells; Adrenal Cortex; Animals; Carrier Proteins; Cholesterol; Cholesterol Esters; Dactinomycin; Epitopes; Fatty Acids, Nonesterified; Lipid Metabolism; Mice; Oleic Acid; Perilipin-1; Phosphoproteins; Polyribosomes; Protein Processing, Post-Translational; RNA, Messenger; Triglycerides | 1997 |
Increased activity of oleate-dependent type phospholipase D during actinomycin D-induced apoptosis in Jurkat T cells.
Topics: Apoptosis; Arachidonic Acid; Cell-Free System; Dactinomycin; Enzyme Activation; Fatty Acids, Unsaturated; Guanosine Triphosphate; HL-60 Cells; Humans; Hydrogen Peroxide; Isoenzymes; Jurkat Cells; Membrane Lipids; Oleic Acid; Phospholipase D; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1998 |
Effects of fatty acids on mitochondrial beta-oxidation enzyme gene expression in renal cell lines.
Topics: Acyl-CoA Dehydrogenase; Acyl-CoA Dehydrogenase, Long-Chain; Animals; Caprylates; Cell Line, Transformed; Clofibrate; Dactinomycin; Dose-Response Relationship, Drug; Fatty Acids; Gene Expression Regulation, Enzymologic; Hypolipidemic Agents; Kidney Tubules; Laurates; Lipid Metabolism; Mitochondria; Oleic Acid; Palmitates; Protein Synthesis Inhibitors; Rabbits; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Transcription Factors | 2002 |
mRNA levels of peroxisome proliferator-activated receptors and their coactivators are affected by glucose deprivation and oleate in human hepatoma hepG2 cells.
Topics: Cell Line, Tumor; Cycloheximide; Dactinomycin; Glucose; Humans; In Vitro Techniques; Liver Neoplasms; Oleic Acid; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2007 |